Pharmacotherapy and pregnancy

Highlights from the third international conference for individualized pharmacotherapy in pregnancy

David M. Haas, Beverly Gallauresi, Kristine Shields, Deborah Zeitlin, Shannon Clark, Mary F. Hebert, Zhaoxia Ren, Srikanth C. Nallani, Eric M. Meslin, Karen B. Feibus, Gideon Koren, W. Scott Goebel, Thomas Easterling, Scott C. Denne, David A. Flockhart, Jamie L. Renbarger

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

Original languageEnglish (US)
Pages (from-to)204-209
Number of pages6
JournalClinical and Translational Science
Volume4
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Drug therapy
Drug Therapy
Pregnancy
Obstetrics
Pharmaceutical Preparations
Medical problems
Labeling
Blood
Personnel
Pharmacology
Blood Banks
Aptitude
Gestational Diabetes
Premature Obstetric Labor
United States Food and Drug Administration
Breast Feeding
Fetal Blood
Pharmacists
Industry
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacotherapy and pregnancy : Highlights from the third international conference for individualized pharmacotherapy in pregnancy. / Haas, David M.; Gallauresi, Beverly; Shields, Kristine; Zeitlin, Deborah; Clark, Shannon; Hebert, Mary F.; Ren, Zhaoxia; Nallani, Srikanth C.; Meslin, Eric M.; Feibus, Karen B.; Koren, Gideon; Goebel, W. Scott; Easterling, Thomas; Denne, Scott C.; Flockhart, David A.; Renbarger, Jamie L.

In: Clinical and Translational Science, Vol. 4, No. 3, 06.2011, p. 204-209.

Research output: Contribution to journalArticle

Haas, DM, Gallauresi, B, Shields, K, Zeitlin, D, Clark, S, Hebert, MF, Ren, Z, Nallani, SC, Meslin, EM, Feibus, KB, Koren, G, Goebel, WS, Easterling, T, Denne, SC, Flockhart, DA & Renbarger, JL 2011, 'Pharmacotherapy and pregnancy: Highlights from the third international conference for individualized pharmacotherapy in pregnancy', Clinical and Translational Science, vol. 4, no. 3, pp. 204-209. https://doi.org/10.1111/j.1752-8062.2011.00280.x
Haas, David M. ; Gallauresi, Beverly ; Shields, Kristine ; Zeitlin, Deborah ; Clark, Shannon ; Hebert, Mary F. ; Ren, Zhaoxia ; Nallani, Srikanth C. ; Meslin, Eric M. ; Feibus, Karen B. ; Koren, Gideon ; Goebel, W. Scott ; Easterling, Thomas ; Denne, Scott C. ; Flockhart, David A. ; Renbarger, Jamie L. / Pharmacotherapy and pregnancy : Highlights from the third international conference for individualized pharmacotherapy in pregnancy. In: Clinical and Translational Science. 2011 ; Vol. 4, No. 3. pp. 204-209.
@article{5c238c78bacf491baefdb62f8349cb7f,
title = "Pharmacotherapy and pregnancy: Highlights from the third international conference for individualized pharmacotherapy in pregnancy",
abstract = "To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.",
author = "Haas, {David M.} and Beverly Gallauresi and Kristine Shields and Deborah Zeitlin and Shannon Clark and Hebert, {Mary F.} and Zhaoxia Ren and Nallani, {Srikanth C.} and Meslin, {Eric M.} and Feibus, {Karen B.} and Gideon Koren and Goebel, {W. Scott} and Thomas Easterling and Denne, {Scott C.} and Flockhart, {David A.} and Renbarger, {Jamie L.}",
year = "2011",
month = "6",
doi = "10.1111/j.1752-8062.2011.00280.x",
language = "English (US)",
volume = "4",
pages = "204--209",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Pharmacotherapy and pregnancy

T2 - Highlights from the third international conference for individualized pharmacotherapy in pregnancy

AU - Haas, David M.

AU - Gallauresi, Beverly

AU - Shields, Kristine

AU - Zeitlin, Deborah

AU - Clark, Shannon

AU - Hebert, Mary F.

AU - Ren, Zhaoxia

AU - Nallani, Srikanth C.

AU - Meslin, Eric M.

AU - Feibus, Karen B.

AU - Koren, Gideon

AU - Goebel, W. Scott

AU - Easterling, Thomas

AU - Denne, Scott C.

AU - Flockhart, David A.

AU - Renbarger, Jamie L.

PY - 2011/6

Y1 - 2011/6

N2 - To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

AB - To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=79959762627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959762627&partnerID=8YFLogxK

U2 - 10.1111/j.1752-8062.2011.00280.x

DO - 10.1111/j.1752-8062.2011.00280.x

M3 - Article

VL - 4

SP - 204

EP - 209

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 3

ER -